Genetic variation in neuroendocrine genes associates with somatic symptoms in the general population: Results from the EPIFUND study

Journal of Psychosomatic Research

Volumn 68, Issue 5, 2010, Pages 469-474

  Holliday, Kate L ^a   Macfarlane, Gary J ^b   Nicholl, Barbara I ^a   Creed, Francis ^a   Thomson, Wendy ^a   McBeth, John ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

(max 6); Genetics; HPA; Polymorphism; Serotonin; Somatisation

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; MELANOCORTIN 2 RECEPTOR; PROOPIOMELANOCORTIN; SEROTONIN 2A RECEPTOR; SEROTONIN TRANSPORTER; TRANSCORTIN; TRYPTOPHAN HYDROXYLASE;

ADULT; ANXIETY; ARTICLE; COHORT ANALYSIS; DEPRESSION; FEMALE; GENETIC VARIABILITY; GENOTYPE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINE SYSTEM; PAIN; POSTAL MAIL; QUESTIONNAIRE; REGISTER; SEROTONINERGIC SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIZATION; STEP WISE MULTIPLE REGRESSION; SYMPTOM; SYMPTOM CHECKLIST 90; UNITED KINGDOM;

ADULT; AGED; ANXIETY; COHORT STUDIES; DEPRESSION; ENGLAND; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MIDDLE AGED; PAIN MEASUREMENT; PITUITARY-ADRENAL SYSTEM; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOPHYSIOLOGIC DISORDERS; QUESTIONNAIRES; REGRESSION ANALYSIS; SEROTONIN; SOMATOFORM DISORDERS;

EID: 77953824896     PISSN: 00223999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2010.01.024     Document Type: Article

References (42)

1. Wessely S, Nimnuan C, Sharpe M Functional somatic syndromes: one or many?. Lancet 1999, 354:936-939.
2. Pellegrino MJ, Waylonis GW, Sommer A Familial occurrence of primary fibromyalgia. Arch Phys Med Rehabil 1989, 70:61-63.
3. Buskila D, Neumann L, Hazanov I, Carmi R Familial aggregation in fibromyalgia syndrome. Semin Arthritis Rheum 1996, 26:605-611.
4. Arnold LM, Hudson JI, Hess EV, Ware AE, Fritz DA, Auchenbach MB, et al. Family study of fibromyalgia. Arthritis Rheum 2004, 50:944-952.
5. Kato K, Sullivan PF, Evengard B, Pedersen NL Importance of genetic influences on chronic widespread pain. Arthritis Rheum 2006, 54:1682-1686.
6. Hickie IB, Bansal AS, Kirk KM, Lloyd AR, Martin NG A twin study of the etiology of prolonged fatigue and immune activation. Twin Res 2001, 4:94-102.
7. Buchwald D, Herrell R, Ashton S, Belcourt M, Schmaling K, Sullivan P, et al. A twin study of chronic fatigue. Psychosom Med 2001, 63:936-943.
8. Morris-Yates A, Talley NJ, Boyce PM, Nandurkar S, Andrews G Evidence of a genetic contribution to functional bowel disorder. Am J Gastroenterol 1998, 93:1311-1317.
9. Bengtson MB, Ronning T, Vatn MH, Harris JR Irritable bowel syndrome in twins: genes and environment. Gut 2006, 55:1754-1759.
10. Mohammed I, Cherkas LF, Riley SA, Spector TD, Trudgill NJ Genetic influences in irritable bowel syndrome: a twin study. Am J Gastroenterol 2005, 100:1340-1344.
11. Levy RL, Jones KR, Whitehead WE, Feld SI, Talley NJ, Corey LA Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology. Gastroenterology 2001, 121:799-804.
12. Lembo A, Zaman M, Jones M, Talley NJ Influence of genetics on irritable bowel syndrome, gastro-oesophageal reflux and dyspepsia: a twin study. Aliment Pharmacol Ther 2007, 25:1343-1350.
13. Lembo AJ, Zaman M, Krueger RF, Tomenson BM, Creed FH Psychiatric disorder, irritable bowel syndrome, and extra-intestinal symptoms in a population-based sample of twins. Am J Gastroenterol 2009, 104:686-694.
14. Kato K, Sullivan PF, Evengard B, Pedersen NL A population-based twin study of functional somatic syndromes. Psychol Med 2008, 1-9.
15. Aggarwal VR, McBeth J, Zakrzewska JM, Lunt M, Macfarlane GJ The epidemiology of chronic syndromes that are frequently unexplained: do they have common associated factors?. Int J Epidemiol 2006, 35:468-476.
16. Nicholl BI, Halder SL, Macfarlane GJ, Thompson DG, O'Brien S, Musleh M, et al. Psychosocial risk markers for new onset irritable bowel syndrome-results of a large prospective population-based study. Pain 2008, 137:147-155.
17. Gupta A, Silman AJ, Ray D, Morriss R, Dickens C, Macfarlane GJ, et al. The role of psychosocial factors in predicting the onset of chronic widespread pain: results from a prospective population-based study. Rheumatology (Oxford) 2007, 46:666-671.
18. Gillespie NA, Zhu G, Heath AC, Hickie IB, Martin NG The genetic aetiology of somatic distress. Psychol Med 2000, 30:1051-1061.
19. Crofford LJ, Pillemer SR, Kalogeras KT Hypothalamic-pituitary-adrenal axis pertubations in patients with fibromyalgia. Arthritis Rheum 1994, 37:1583-1592.
20. McBeth J, Silman AJ, Gupta A, Chiu YH, Ray D, Morriss R, et al. Moderation of psychosocial risk factors through dysfunction of the hypothalamic-pituitary-adrenal stress axis in the onset of chronic widespread musculoskeletal pain: findings of a population-based prospective cohort study. Arthritis Rheum 2007, 56:360-371.
21. Russell IJ, Vipraio GA, Lopez YG Serum serotonin in fibromyalgia syndrome, rheumatoid arthritis and healthy normal controls. Arthritis Rheum 1993, 36:S222.
22. Wolfe F, Russell IJ, Vipraio G, Ross K, Anderson J Serotonin levels, pain threshold, and fibromyalgia symptoms in the general population. J Rheumatol 1997, 24:555-559.
23. Nicholl BI, Limer KL, Macfarlane GJ, Thomson W, Davies KA, McBeth J Genetic Variation in the Serotonin Pathway Is Associated with Chronic Widespread Pain: Results from the Epifund Study. Rheumatology (Oxford) 2009, 48:I14.
24. Holliday KL, Nicholl BI, Macfarlane GJ, Thomson W, Davies KA, McBeth J Genetic variation in the hypothalamic-pituitary-adrenal stress axis influences susceptibility to musculoskeletal pain: Results from the EPIFUND study. Ann Rheum Dis 2009, Published Online First: 31 August 2009. 10.1136/ard.2009.116137.
25. Tak LM, Rosmalen JG Psychoneuroendocrinology of functional somatic disorders. Psychoneuroendocrinology Research Trends 2007, 463-495. Nova Science Publishers, Inc. M.T. Czerbska (Ed.).
26. O'Malley PG, Jackson JL, Santoro J, Tomkins G, Balden E, Kroenke K Antidepressant therapy for unexplained symptoms and symptom syndromes. J Fam Pract 1999, 48:980-990.
27. Creed F How do SSRIs help patients with irritable bowel syndrome?. Gut 2006, 55:1065-1067.
28. Othmer E, DeSouza C A screening test for somatization disorder (hysteria). Am J Psychiatry 1985, 142:1146-1149.
29. Zigmond AS, Snaith RP The hospital anxiety and depression scale. Acta Psychiatr Scand 1983, 67:361-370.
30. Hunt IM, Silman AJ, Benjamin S, McBeth J, Macfarlane GJ The prevalence and associated features of chronic widespread pain in the community using the 'Manchester' definition of chronic widespread pain. Rheumatology (Oxford) 1999, 38:275-279.
31. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D Efficiency and power in genetic association studies. Nat Genet 2005, 37:1217-1223.
32. Barrett JC, Fry B, Maller J, Daly MJ Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
33. Gursoy S, Erdal E, Herken H, Madenci E, Alasehirli B Association of T102C polymorphism of the 5-HT2A receptor gene with psychiatric status in fibromyalgia syndrome. Rheumatol Int 2001, 21:58-61.
34. Bondy B, Spaeth M, Offenbaecher M, Glatzeder K, Stratz T, Schwarz M, et al. The T102C polymorphism of the 5-HT2A-receptor gene in fibromyalgia. Neurobiol Dis 1999, 6:433-439.
35. Smith AK, Dimulescu I, Falkenberg VR, Narasimhan S, Heim C, Vernon SD, et al. Genetic evaluation of the serotonergic system in chronic fatigue syndrome. Psychoneuroendocrinology 2008, 33:188-197.
36. Mutlu N, Erdal ME, Herken H, Oz G, Bayazit YA T102C polymorphism of the 5-HT2A receptor gene may be associated with temporomandibular dysfunction. Oral Dis 2004, 10:349-352.
37. Tander B, Gunes S, Boke O, Alayli G, Kara N, Bagci H, et al. Polymorphisms of the serotonin-2A receptor and catechol-O-methyltransferase genes: a study on fibromyalgia susceptibility. Rheumatol Int 2008, 28:685-691.
38. McBeth J, Macfarlane GJ, Benjamin S, Silman AJ Features of somatization predict the onset of chronic widespread pain: results of a large population-based study. Arthritis Rheum 2001, 44:940-946.
39. Kroenke K, Spitzer RL, Williams JB The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med 2002, 64:258-266.
40. Barsky AJ, Orav EJ, Bates DW Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Arch Gen Psychiatry 2005, 62:903-910.
41. Li J, Ji L Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity 2005, 95:221-227.
42. Creed F, Barsky A A systematic review of the epidemiology of somatisation disorder and hypochondriasis. J Psychosom Res 2004, 56:391-408.